Ozempic Pre-filled Pen | Weight Management | Sorted Wellness

Active ingredient

Semaglutide.

Formulation and available strengths

Pre-filled solution for subcutaneous injection, available in listed weekly doses of 0.25 mg, 0.5 mg, 1 mg and 2 mg.

Licensed dosage guidance

Licensed UK adult type 2 diabetes schedule: initiate 0.25 mg once weekly for four weeks, then 0.5 mg weekly. The prescriber may consider 1 mg and subsequently 2 mg after at least four weeks at each previous dose, for glycaemic control.

How it is taken

Subcutaneous injection once weekly. Ozempic is licensed for type 2 diabetes, not for weight management as a specific UK indication; placing it in this collection does not change that licensing.

Clinical guidance: The dose sequence below is general information from the UK-approved product information, not an individual prescription. Do not start, change or restart a medicine without assessment and specific instructions from the prescriber.

Safety: Discuss your medical history, pregnancy or breastfeeding, previous pancreatitis or gallbladder problems, allergies, kidney problems and all current medicines with your clinician. Side effects and contraindications vary by product; consult the supplied patient information leaflet.

Other ingredients: Inactive ingredients and excipients may vary by strength, formulation and manufacturer. The exact dispensed pack's patient information leaflet is the authoritative list and should be checked for allergies or intolerances.

Supply: Subject to clinical assessment, prescription where required, and pharmacy approval. Product availability and the dispensed pack must be confirmed by Faces Pharmacy.

UK product information: Read the reference for detailed precautions, excipients and dosing.